Dear Kerri,
following HGVS nomenclature the variant should be described as NC_000012.12:g.32792425_32792430del NM_001005242.3:c.2510_*1del p.(Asp837GlyfsTer3).
Note that HGVS demands that "all variants should be described at the most basic level, the DNA level.
Descriptions on the RNA and/or protein level may be given in addition", see Geneneral recommendations.
Furthermore, HGVS does not allow the addition of gene symbols in variant nomencalture, so "NM_001005242.3(PKP2):c.2510_*1del" should not be used.
As you mention, the variant cannot be described as an "extension" since the last amino acid is changed, the variant is therefore a frame shift (Recommendations > Protein > Frame shift: "deletions starting 5' of and including the translation termination (stop) codon are described as frameshift").
When I tried, both VariantValidator and Mutalyzer give "p.(Asp837GlyfsTer3)" as the predicted consequences at protein level.
Best regards,
Johan den Dunnen
HUGO HGVS Variant Nomenclature Committee (HVNC)